MedPath

Validation of the Clinical and Antimicrobial Effectiveness of a Clorexidine and Sodium DNA Based Mouthwash in Patients With Stage III and IV Periodontitis

Not Applicable
Completed
Conditions
Periodontitis
Interventions
Procedure: Non-surgical periodontal treatment
Registration Number
NCT06028867
Lead Sponsor
University of Catania
Brief Summary

Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCT study is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis.

Detailed Description

Sodium DNA has several properties that may be beneficial in the management of bacterial biofilm in periodontitis. The aim of this RCTstudy is to clinically evaluate the antimicrobial and oral biofilm control properties of two mouthwashes containing Chlorhexidine 0.12% + Sodium DNA and Chlorhexidine 0.20% at two weeks, compared with a placebo, on patients with stage III or IV periodontitis. The study was designed as a double-blind randomized controlled trial (RCT) with three parallel groups of individuals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria

• Clinically diagnosed with stage III or IV periodontitis according to the EFP/AAP 2017 criteria.

Exclusion Criteria
  • Periodontal treatment, antibiotics, NSAIDs, immunosuppressants during the last 6 months.
  • Pregnancy.
  • Systemic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chlorhexidine 0,20% mouthwashNon-surgical periodontal treatmentPatients are treated with a mouthwash containing Chlorhexidine 0,20%
Placebo mouthwashNon-surgical periodontal treatmentPatients are treated with a placebo mouthwash
Chlorhexidine 0,12% + Sodium DNA mouthwashNon-surgical periodontal treatmentPatients are treated with a mouthwash containing Chlorhexidine 0,12% + Sodium DNA
Primary Outcome Measures
NameTimeMethod
Subgingival biofilm2 weeks

Subgingival biofilm collected with sterile paper strips and analyzed by polimerase chain reaction

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AOU Policlinico G. Rodolico

🇮🇹

Catania, Italy

© Copyright 2025. All Rights Reserved by MedPath